Measuring NAD⁺ levels in mouse blood and tissue samples via a surrogate matrix approach using LC–MS/MS

References

• 1 Rechsteiner M, Hillyard D, Olivera BM. Magnitude and significance of NAD turnover in human cell line D98/AH2. Nature 259(5545), 695–696 (1976).
  Medline CASGoogle Scholar
• 2 Chambon P, Weill JD, Mandel P. Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme. Biochem. Biophys. Res. Commun. 11, 39–43 (1963).
  Medline CASGoogle Scholar
• 3 Chambon P, Weill JD, Doly J, Strosser MT, Mandel P. On the formation of a novel adenylic compound by enzymatic extracts of liver nuclei Biochem. Biophys. Res. Commun. 25(6), 638–643 (1966).
  CASGoogle Scholar
• 4 Corda D, Di Girolamo M. Functional aspects of protein mono-ADP-ribosylation. EMBO J. 22(9), 1953–1958 (2003).
  Medline CASGoogle Scholar
• 5 Luo J, Nikolaev AY, Imai S et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107(2), 137–148 (2001).
  Medline CASGoogle Scholar
• 6 Bouras T, Fu M, Sauve AA et al. SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. J. Biol. Chem. 280(11), 10264–10276 (2005).
  Medline CASGoogle Scholar
• 7 Sauve AA. NAD⁺ and vitamin B3: from metabolism to therapies. J. Pharmacol. Exp. Ther. 324(3), 883–893 (2008).
  Medline CASGoogle Scholar
• 8 Smith JS, Boeke JD. An unusual form of transcriptional silencing in yeast ribosomal DNA. Genes Dev. 11(2), 241–254 (1997).
  Medline CASGoogle Scholar
• 9 Sandmeier JJ, Celic I, Boeke JD, Smith JS. Telomeric and rDNA silencing in Saccharomyces cerevisiae are dependent on a nuclear NAD⁺ salvage pathway. Genetics 160(3), 877–889 (2002).
  Medline CASGoogle Scholar
• 10 Garcia Soriano F, Virag L, Jagtap P et al. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat. Med. 7(1), 108–113 (2001).
  Medline CASGoogle Scholar
• 11 Greenamyre JT, Sherer TB, Betarbet R, Panov AV. Complex I and Parkinson’s disease. IUBMB Life 52(3–5), 135–141 (2001).
  Medline CASGoogle Scholar
• 12 Zhang Q, Piston DW, Goodman RH. Regulation of corepressor function by nuclear NADH. Science 295(5561), 1895–1897 (2002).
  Medline CASGoogle Scholar
• 13 Locasale JW, Cantley LC. Altered metabolism in cancer. BMC Biol. 8, 88 (2010).
  MedlineGoogle Scholar
• 14 Litt MR, Potter JJ, Mezey E, Mitchell MC. Analysis of pyridine dinucleotides in cultured rat hepatocytes by high-performance liquid chromatography. Anal. Biochem. 179(1), 34–36 (1989).
  Medline CASGoogle Scholar
• 15 Ryll T, Wagner R. Improved ion-pair high-performance liquid chromatographic method for the quantification of a wide variety of nucleotides and sugar-nucleotides in animal cells. J. Chromatogr. 570(1), 77–88 (1991).
  Medline CASGoogle Scholar
• 16 Neves AR, Ventura R, Mansour, N et al. Is the glycolytic flux in Lactococcus lactis primarily controlled by the redox charge? Kinetics of NAD⁺ and NADH pools determined in vivo by 13C NMR. J. Biol. Chem. 277(31), 28088–28098 (2002).
  Medline CASGoogle Scholar
• 17 Anderson RM, Latorre-Esteves M, Neves AR et al. Yeast life-span extension by calorie restriction is independent of NAD fluctuation. Science 302(5653), 2124–2126 (2003).
  Medline CASGoogle Scholar
• 18 Putt KS, Hergenrother PJ. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD⁺: application to the high-throughput screening of small molecules as potential inhibitors. Anal. Biochem. 326(1), 78–86 (2004).
  Medline CASGoogle Scholar
• 19 Sporty JL, Kabir MM, Turteltaub KW, Ognibene T, Lin SJ, Bench G. Single sample extraction protocol for the quantification of NAD and NADH redox states in Saccharomyces cerevisiae. J. Sep. Sci. 31(18), 3202–3211 (2008).
  Medline CASGoogle Scholar
• 20 Stocchi V, Cucchiarini L, Magnani M, Fornaini G. Adenine and pyridine nucleotides in the erythrocyte of different mammalian species. Biochem. Int. 14(6), 1043–1053 (1987).
  Medline CASGoogle Scholar
• 21 Yamada K, Hara N, Shibata T, Osago H, Tsuchiya M. The simultaneous measurement of nicotinamide adenine dinucleotide and related compounds by liquid chromatography/electrospray ionization tandem mass spectrometry. Anal. Biochem. 352(2), 282–285 (2006).
  Medline CASGoogle Scholar
• 22 Evans C, Bogan KL, Song P, Burant CF, Kennedy RT, Brenner C. NAD⁺ metabolite levels as a function of vitamins and calorie restriction: evidence for different mechanisms of longevity. BMC Chem. Biol. 10, 2 (2010).
  MedlineGoogle Scholar
• 23 Klawitter J, Schmitz V, Leibfritz D, Christians U. Development and validation of an assay for the quantification of 11 nucleotides using LC/LC-electrospray ionization-MS. Anal. Biochem. 365(2), 230–239 (2007).
  Medline CASGoogle Scholar
• 24 O’Reilly T, Niven DF. Levels of nicotinamide adenine dinucleotide in extracellular body fluids of pigs may be growth-limiting for Actinobacillus pleuropneumoniae and Haemophilus parasuis. Can. J. Vet. Res. 67(3), 229–231 (2003).
  MedlineGoogle Scholar
• 25 Micheli V, Simmonds HA, Sestini S, Ricci C. Importance of nicotinamide as an NAD precursor in the human erythrocyte. Arch. Biochem. Biophys. 283(1), 40–45 (1990).
  Medline CASGoogle Scholar
• 26 Zheng X, Bauer P, Baumeister T et al. Structure-based identification of ureas as novel nicotinamide phosphoribosyltransferase (NAMPT) inhibitors. J. Med. Chem. 56(12), 4921–4937 (2013).
  Medline CASGoogle Scholar
• 27 Mikhailopulo IA, Pricota TI, Timoshchuk VA, Akhrem AA. Synthesis of glycosides of nicotinamide and nicotinamide mono-nucleotide. Synthesis-Stuttgart (5), 388–389 (1981).
  Google Scholar
• 28 Yang T, Chan NY, Sauve AA. Syntheses of nicotinamide riboside and derivatives: effective agents for increasing nicotinamide adenine dinucleotide concentrations in mammalian cells. J. Med. Chem. 50(26), 6458–6461 (2007).
  Medline CASGoogle Scholar
• 29 Lee J, Churchil H, Choi WB et al. A chemical synthesis of nicotinamide adenine dinucleotide (NAD⁺). Chem. Commun. (8), 729–730 (1999).
  Google Scholar
• 30 Liang X, Ubhayakar S, Liederer BM et al. Evaluation of homogenization techniques for the preparation of mouse tissue samples to support drug discovery. Bioanalysis 3(17), 1923–1933 (2011).
  CASGoogle Scholar
• 31 Jones BR, Schultz GA, Eckstein JA, Ackermann BL. Surrogate matrix and surrogate analyte approaches for definitive quantitation of endogenous biomolecules. Bioanalysis 4(19), 2343–2356 (2012).
  CASGoogle Scholar
• 32 Oppenheimer NJ. NAD hydrolysis: chemical and enzymatic mechanisms. Mol. Cell Biochem. 138(1–2), 245–251 (1994).
  Medline CASGoogle Scholar
• 33 Jedeikin LA, Weinhouse S. Metabolism of neoplastic tissue. VI. Assay of oxidized and reduced diphosphopyridine nucleotide in normal and neoplastic tissues. J. Biol. Chem. 213(1), 271–280 (1955).
  Medline CASGoogle Scholar
• 34 Powanda MC, Wannemacher RW, Jr.. Evidence for a linear correlation between the level of dietary tryptophan and hepatic NAD concentration and for a systematic variation in tissue NAD concentration in the mouse and the rat. J. Nutr. 100(12), 1471–1478 (1970).
  Medline CASGoogle Scholar
• 35 Xiao Y, Elkins K, Durieux JK et al. Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618. Neoplasia 15(10), 1151–1160 (2013).
  MedlineGoogle Scholar
• 36 Zheng X, Bair KW, Bauer P et al. Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). Bioorg. Med. Chem. Lett. 23(20), 5488–5497 (2013).
  Medline CASGoogle Scholar